UW spinoff company launches clinical trial for metastatic cancer treatment
The first patient in a clinical trial led by Archeus Technologies has received a dose of an investigational therapy to treat metastatic cancer, developed by the clinical-stage company which has ties to the University of Wisconsin–Madison, UW Health’s Isthmus Project and the Wisconsin Alumni Research Foundation.
Research agreement signed with Accuray to improve personalized cancer care
A new 10‑year strategic collaboration between the University of Wisconsin School of Medicine and Public Health and Accuray Incorporated will support clinical research, education and training, and development of adaptive therapies that help empower medical care teams to continually raise the standard in cancer care.
Christian Capitini named director of the UW Carbone Cancer Center
The University of Wisconsin School of Medicine and Public Health and UW Health are pleased to announce that Dr. Christian Capitini, a national expert in the treatment and research of childhood cancers, has been named the next director of the University of Wisconsin Carbone Cancer Center. He will assume the role of Carbone Cancer Center director on April 19.
Eight researchers transforming colorectal cancer care
March is National Colorectal Cancer Awareness Month, established to raise awareness for a disease that is largely preventable. Colorectal cancer is now the leading cause of cancer death in adults under 50 and the only major cancer where mortality is rising in younger adults, according to a 2026 report from the American Cancer Society.
How AI is advancing medical research
Able to absorb, examine and analyze staggering amounts of data, artificial intelligence (AI) helps medical researchers identify disease patterns and predict patient outcomes.
UW–Madison and Immuto Scientific to collaborate on novel cancer target discovery
University of Wisconsin–Madison and Immuto Scientific have officially entered into a collaborative agreement to identify disease-specific, novel therapeutic targets in colorectal cancer.
Radiopharmaceutical research agreement signed with NorthStar Medical Radioisotopes
A new agreement between the University of Wisconsin School of Medicine and Public Health and NorthStar Medical Radioisotopes, LLC (NorthStar) is aimed at advancing research and supporting workforce development in the nuclear medicine sector.
Q&A: Joshua Lang on new research on treatment-resistant prostate cancer
A five-year, $12.5 million grant has been awarded to researchers at UW–Madison to investigate metastatic, or advanced stage, prostate cancer, the second most common cause of cancer death in men.
An early roadmap to preventing a devastating childhood brain cancer
Stopping genetic mutations that cause a rare but aggressive brain tumor in children may be the key to preventing the cancer’s development in the first place, according to researchers in the UW School of Medicine and Public Health.
UW–Madison to lead nation in boron neutron capture therapy for cancer
The University of Wisconsin–Madison and TAE Life Sciences, a biotechnology company specializing in targeted radiation therapy for cancer care, have signed a memorandum of understanding, or MOU, announcing the intention to launch the first accelerator-based boron neutron capture therapy (BNCT) center in the United States.
Researching voice disorders is top strength of new department
UW is known nationwide for its expertise in laryngology, the care of patients with voice, airway and swallowing disorders. The specialty is a key strength of the new Department of Otolaryngology-Head and Neck Surgery, which became the school’s 28th department in June after nine decades of growth and innovation as a division within the Department of Surgery.
Q&A: Jacques Galipeau on cell therapies to cure disease
Dr. Jacques Galipeau is the associate dean for therapeutics development and the director of the Program for Advanced Cell Therapy (PACT), a collaboration between UW Health and the University of Wisconsin School of Medicine and Public Health that aims to bring innovative cell therapies to patients. He is also a practicing hematologist, treating patients with blood clot disorders, anemia, and other diseases and conditions.